Biogen Idec

3 Biotech Favorites With Noteworthy Drug Data
Motley Fool
Mon, 07/29/13 - 03:05 pm
Alexion
Biogen Idec
Soliris
Celgene
Revlimid
Tecfidera
Drug developer Biogen's 2nd quarter profit climbs 27 percent, as new MS drug adds to revenue
Yahoo/AP
Thu, 07/25/13 - 10:59 am
earnings
Biogen Idec
Can Biogen Keep The Party Going After A Flawless Drug Launch? Comment Now Follow Comments
Forbes
Thu, 07/25/13 - 09:49 am
drug launches
Biogen Idec
Tecfidera
MS
multiple sclerosis
A Biotech Betting Everything on a Single Drug
Motley Fool
Wed, 07/24/13 - 11:46 am
Questcor
Pfizer
Biogen Idec
Acthar
Novartis
Biogen shares slip on MS patient death, company says no connection
Marketwatch
Wed, 07/24/13 - 09:56 am
Biogen Idec
MS
multiple sclerosis
Tecfidera
Watch Out for These 3 Biotech Companies
Motley Fool
Thu, 07/4/13 - 11:23 am
Biogen Idec
Biocad
Amgen
M&A
Celgene
MorphoSys
Tecfidera
Biogen investors encouraged by ruling on rival drug, shares jump
Marketwatch
Fri, 06/28/13 - 12:19 pm
Biogen Idec
Sanofi
Aubagio
Tecfidera
MS
multiple sclerosis
3 Best-Run Biotech Companies
Motley Fool
Sun, 06/23/13 - 11:12 am
Biogen Idec
Alexion
Questcor Pharmaceuticals
Biogen's impressive Tecfidera launch hits reimbursement, supply snags
Fierce Pharma
Wed, 06/19/13 - 04:07 pm
Biogen Idec
Tecfidera
reimbursement
MS
multiple sclerosis
drug launches
Novartis: 5-Year Revenue Outlook
Seeking Alpha
Thu, 06/13/13 - 10:23 am
Novartis
Sanofi
Biogen Idec
Biogen MS drug scripts up 12% in week eight, says Citigroup
The Fly on the Wall
Mon, 06/3/13 - 12:40 pm
MS
Biogen Idec
multiple sclerosis
Tecfidera
Takeda, Biogen, Article One: Intellectual Property
Bloomberg
Fri, 05/31/13 - 09:07 am
Takeda
Biogen Idec
intellectual property
Novartis
Dexilant
generics
Sandoz
Tecfidera
Impax Laboratories
Biogen’s MS Pill Delayed in Europe as Patent Extended
Bloomberg
Thu, 05/30/13 - 11:34 am
Biogen Idec
Europe
patents
MS
multiple sclerosis
Tecfidera
Biogen Idec's MS Drug Launch Is Going Amazingly Well. These Two Graphs Prove It
Forbes
Wed, 05/29/13 - 04:31 pm
drug launches
MS
multiple sclerosis
Biogen Idec
Tecfidera
5 Drugs Stocks Driving The Industry Higher
TheStreet.com
Tue, 05/28/13 - 06:13 pm
Biogen Idec
Amgen
Valeant Pharmaceuticals
Celgene
Abbott Laboratories
AstraZeneca
Tiny Biotech Developing Drugs Akin To Biogen's Rituxan Seen As Potential Buyout Bet
Forbes
Mon, 05/27/13 - 08:17 pm
Biogen Idec
Rituxan
TG Therapeutics
Utuxin
TGR-1202
CLL
chronic lymphocytic leukemia
non-Hodgkin's lymphoma
Biogen Idec submits Plegridy to FDA for multiple sclerosis patients with relapsed disease
Yahoo/AP
Wed, 05/22/13 - 09:43 am
Biogen Idec
MS
multiple sclerosis
FDA
Plegridy
Leading Biotechs Act Well But Be Careful Not To Chase
Investors.com
Tue, 05/7/13 - 11:39 am
Biogen Idec
Regeneron
Amgen
Celgene
Gilead
The Biogen MS Pill: The 'Holy Mother' Of All Drug Launches?
Pharmalot
Mon, 04/29/13 - 11:40 am
Biogen Idec
Tecfidera
drug launches
MS
multiple sclerosis
Biogen MS Pill’s Early Sales May Help It Beat Estimates
Bloomberg
Mon, 04/29/13 - 10:52 am
MS
multiple sclerosis
Biogen Idec
BG-12
Tecfidera

Pages